suggests more than a single pathological process.
Sickle cell hemoglobin S (HbS) and hemoglobin C (HbC) are structural variants of ␤-globin that differ from each other by a single amino acid residue.
1 ␣-Thalassemias result from an impaired production of ␣-globin, whereby ␣ ϩ -and ␣ 0 -forms are caused by deletions that leave 1 functional copy of the duplicated ␣-globin genes and abolish both of them, respectively. In Africa, the clinically silent −␣ 3.7 deletion prevails, and ␣ 0 -thalassemias are rare. 1 Sickle cell hemoglobin S has long been recognized as protective against mild and severe malaria, and the high degree of protection found in various, often heterogeneous, study groups sug-gests that it has an effect on most if not all forms of clinical malaria. [6] [7] [8] [9] [10] In contrast, malaria protection afforded by HbC and −␣ has been more difficult to confirm. 6, 7 More recently, several studies have indicated that both confer significant protection against the severe form of the disease. [9] [10] [11] [12] [13] [14] However, certain lines of evidence raise the question of whether HbC and −␣ provide equal protection from all forms of severe malaria. [10] [11] [12] Data obtained in a small patient group suggested that −␣ might be negatively associated with severe anemia only. 15, 16 Hemoglobin C was recently found to inhibit the adherence of P falciparum-infected erythrocytes to vascular endothelial cells in vitro. 17 Because postmortem findings of parasitized cells sequestered in small blood vessels of the brain are considered the hallmark of cerebral malaria, 18 the in vitro finding may suggest that HbC may have a particular influence on this form of the disease.
After studying more than 2500 children with severe falciparum malaria, we determined the associations of HbS, HbC, and −␣ with the syndrome as a whole and with cerebral malaria and severe anemia specifically.
METHODS

Study Participants
Ethical approval was obtained from the Committee for Research, Publications and Ethics of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. All procedures were explained to parents or guardians of the participating children in the local language, and written or thumb-printed informed consent was obtained.
Patients were recruited in Komfo Anokye Teaching Hospital, a tertiary referral center in Kumasi, between 2001 and 2005 in parallel with the Severe Malaria in African Children study. 19 All patients aged 6 months to 10 years were screened for malaria parasitemia using Giemsa-stained blood films. In patients with malaria, the consciousness level according to the Blantyre Coma Score (BCS) 2 was determined at the time of admission, as were acid-base status and blood concentrations of glucose, lactate, and hemoglobin. Patients positive for asexual P falciparum parasitemia with either a BCS less than 3, hemoglobin concentration less than 5 g/dL, or lactate concentration greater than 5 mmol/L were enrolled after consent had been obtained from accompanying parents or guardians.
2 Parasite densities were determined per 200 leukocytes and calculated assuming a leukocyte count of 8000 cells/µL of blood. 20 Prostration (age-dependent incapacity of the child to suck, sit, stand, or walk) and respiratory distress (irregular or deep, acidotic breathing) were assessed in addition to the BCS, which was repeated 1 hour after admission. Cerebral malaria was defined by a BCS of less than 3 for at least 1 hour with or without convulsions; patients with convulsions and a higher BCS were not included because of uncertainties in excluding febrile seizures. Lumbar puncture was performed on unconscious patients, and those with cerebrospinal fluid findings indicative of meningitis were excluded. Blood culture was performed on a minority of patients at the discretion of the admitting physician, but the results were not recorded. Patients with parasite densities greater than 200 000 parasites/µL were classified as hyperparasitemic; those with a base deficit greater than 5.0 mEq/L as acidotic; and those with a blood glucose level less than 39.6 mg/dL (2.2 mmol/L) as hypoglycemic. Jaundice, hemoglobinuria, and abnormal bleeding are rare signs of severe malaria in this setting and were not recorded. Patients were treated according to local guidelines.
Control participants were identified by community surveys designed to search for children, frequencymatching the patients for age, sex, and ethnicity. Ethnicity was determined by the participants using investigatordefined categories. Children were recruited who appeared healthy by physical examination and did not have serious illness according to information provided by parents or guardians.
Genotyping
From patients and controls, 0.5 to 1 mL of venous blood was collected into citrate and subjected to densitygradient centrifugation. The granulocyte fraction was stored in 4-M urea and used for DNA extraction (NucleoMag 96 Blood; Macherey-Nagel, Dü ren, Germany). Genotyping for HbS, HbC, and the −␣ 3.7 deletion was performed 21, 22 using a LightTyper (Roche Diagnostics, Basel, Switzerland) for the analysis of HbS and HbC.
Statistical Analysis
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using STATA version 9.2 (StataCorp, College Station, Tex). All statistical analyses were 2-sided; PϽ.05 was considered significant. For multivariate analyses, multiple logistic regressions were performed to evaluate the effects of genotypes on phenotypes, including adjustments for age, sex, and ethnicity and for mutual influences of ␣-and ␤-globin variants. For all comparisons, the control group (n=2048) was used as the reference group. Coefficients were log-transformed to calculate the ORs and CIs. Proportions of categorical variables were compared by 2 tests. In continuous exposures, Wilcoxon or Kruskall-Wallis tests were performed. The assumption of a HardyWeinberg equilibrium was tested using a z test based on a statistic. Odds ratios obtained in subgroups were compared using tests of interaction and expressed as OR ratios. 23 Epistasis was assessed by performing the Wald test on interactions between ␣-and ␤-globin genotypes in a logistic regression including age, sex, and ethnicity as covariates.
RESULTS
The study group consisted of 2591 children with severe falciparum malaria and 2048 apparently healthy control participants matched for age, sex, and ethnicity ( Patients and controls were compared regarding ␣-and ␤-globin genotype frequencies by multiple logistic regression including adjustments for age, sex, and ethnicity and for mutual influences of ␣-and ␤-globin variants.
Evaluating the entire case group collectively, HbAS was found much less frequently among patients than among controls, indicating a strong negative association (TABLE 3) . In contrast, no significant negative association was found with heterozygous HbC (HbAC). Likewise, associations of homozygous HbC and hemoglobin C disease (HbSC) were not significant (OR, 0.38; 95% CI, 0.13-1.06; P =.07; and OR, 0.44; 95% CI, 0.18-1.04; P = .06, respectively), whereby low genotype frequencies limited accuracy and statistical power of these assessments. Heterozygous −␣ (−␣/␣␣) showed a significant negative association with disease (Table 3) , whereas a negative association of the homozygous form (−␣/−␣) was not statistically significant (OR, 0.67; 95% CI, , %||  59  59  52  59  40  67  58  61  67 Abbreviations: −␣/−␣, homozygous ␣ ϩ -thalassemia; −␣/␣␣, heterozygous ␣ ϩ -thalassemia; ␣␣/␣␣, homozygous wild-type genotype for ␣-globin; HbAA, homozygous wild-type genotype for ␤-globin; HbAC, heterozygous hemoglobin C; HbAS, heterozygous sickle cell hemoglobin; HbCC, homozygous hemoglobin C; HbSC, hemoglobin C disease. *Children with sickle cell disease were excluded because, often being severely anemic per se, 24 they could not be classified with regard to severe malaria anemia. Values of subgroups were compared using Kruskal-Wallis or Mann-Whitney tests; no significant differences were obtained except when noted, whereby P values were corrected for multiple comparisons of the 10 independent parameters of age, sex, parasite density, hemoglobin concentration, cerebral malaria, prostration, respiratory distress, lactate concentration, and acidosis. †Different from HbAA and HbAC (Mann-Whitney test, corrected P = .02 and P = .03, respectively), which is in accordance with previous findings. Because the low genotype frequencies of homozygotes and compound heterozygotes limited the statistical power substantially, we restricted further analyses to heterozygotes. Based on evidence obtained in previous studies, [15] [16] [17] [18] the patient group was stratified for severe anemia and cerebral malaria. Heterozygous HbS showed clear negative associations in both subgroups (Table 3) . A significant negative association of HbAC was found in the subgroup of patients with cerebral malaria but not in that of patients with severe anemia. Negative associations of −␣/␣␣ were found in both subgroups, whereby only the association with severe anemia was significant when P values were corrected for multiple comparisons (Table 3) .
The patient group showed a substantial overlap of signs of disease. For example, of 1649 patients with severe anemia, 1368 had additional signs of malaria and 148 of these had cerebral malaria. Of 581 patients with cerebral malaria, 499 had additional signs, including severe anemia (n = 148). Because the overlap could have caused confounding effects, stratifications and subgroup analyses were performed addressing all major signs of severe falciparum malaria, including-in addition to severe anemia and cerebral malaria-respiratory distress, hyperparasitemia, extreme weakness (termed prostration), hyperlactatemia, and acidosis.
Heterozygous HbS showed a uniform pattern of negative associations in all subgroups studied (FIGURE). Negative associations of HbAC were exclusively seen in subgroups containing patients with cerebral malaria, thereby confirming the selectivity of association with this sign of the disease.
The stratification resulted in a subgroup of patients with cerebral malaria alone, ie, cerebral malaria in the absence of other signs of the disease (n = 82). With an OR of 0.94, this subgroup showed no negative association with HbAC (Figure) . The difference in ORs compared with the main cerebral malaria subgroup was, however, not significant (OR ratio, 1.59; 95% CI, 0.68-3.73; uncorrected P=.28).
In the case of −␣/␣␣, stratifications for the presence or absence of severe anemia revealed a consistent pattern in that ORs were substantially lower in all subgroups of patients with severe anemia than in those without (Figure) . Together with the statistical analysis presented above (Table 3) , these findings indicate that the negative association of −␣/␣␣ with severe falciparum malaria is restricted to severe anemia. Stratifications for the presence or absence of cerebral malaria showed a certain negative association with −␣/␣␣ in most subgroups studied (Figure) , which may relate to the particularly broad overlap between severe anemia and other signs resulting in 59% of cases in these subgroups having concomitant severe anemia.
Similar to the results obtained with HbAC, the further stratification resulted in a subgroup of patients with severe anemia alone, ie, severe anemia in the absence of additional signs of disease, and this subgroup showed no negative association with −␣/␣␣. This subgroup was of considerable size (n=281), and the OR differed significantly from that in the main severeanemia subgroup (OR, 1.08 vs 0.76 [ Figure] ; OR ratio, 1.42; 95% CI, 1.02-1.99; uncorrected P=.04). However, the statistical significance is questionable, because the data result from multiple comparisons.
COMMENT
Our results indicate that, whereas HbAS was negatively associated with all forms of severe falciparum malaria studied, the negative associations of HbAC and −␣/␣␣ were restricted to cerebral malaria and severe anemia, respectively. Extensive Abbreviations: −␣/␣␣, heterozygous ␣ ϩ -thalassemia; ␣␣/␣␣, homozygous wild-type genotype for ␣-globin; CI, confidence interval; HbAA, homozygous wild-type genotype for ␤-globin; HbAC, heterozygous hemoglobin C; HbAS, heterozygous sickle cell hemoglobin; OR, odds ratio. *Assessed by logistic regression compared with all controls adjusting for age, sex, and ethnicity, and mutual influences of ␣-and ␤-globin genotypes.
†P values corrected for 2 comparisons (severe anemia and cerebral malaria; the analyses of negative associations with severe malaria collectively [total] were hypothesis-driven). subgroup analyses indicated that the selectivity of the HbAC and −␣/␣␣ associations was not caused by confounding effects of other signs of the disease. Therefore, it may be concluded that HbAC selectively protects against cerebral malaria and that −␣/␣␣ selectively protects against severe anemia.
Figure. Pattern of Malaria Protection by Heterozygous Variants of Hemoglobin S (HbAS), Hemoglobin C (HbAC), and Heterozygous
Protection by HbAS appeared to exceed 90% in the study group as a whole and 80% in all subgroups. Although the latter had previously not been shown formally, it could have been predicted from the consistently high degrees of protection that had been found in heterogeneous patient groups. [6] [7] [8] [9] [10] A significant epistatic effect between −␣ and HbAS has previously been reported 26 that was limited to the homozygous form −␣/−␣. While we could not assess the interaction between −␣/−␣ and HbAS in our study population because of low genotype frequency of −␣/−␣, we did find marginal but significant epistasis between heterozygous −␣/␣␣ and HbAS and thereby extend the previous observation. No significant epistasis was found between −␣/␣␣ and HbAC. Epistasis was not addressed in any of the subgroup analyses because it influenced the HbAS effect only, which was not the focus of the present study, and because it was marginal and not significant in any of the subgroups studied.
In comparison to the findings obtained with HbAS, the selectivity of the HbAC association for cerebral malaria is remarkable, given the close structural similarity between HbS and HbC. 1 That no significant negative association of HbAC with severe malaria was seen collectively may be the result of the relatively small proportion of patients with cerebral malaria enrolled in our study group (22% [581/2591]), which in part may be due to stringent inclusion criteria. In previous studies describing such an association, 51% (34/67) and 39% (115/290) of the study groups comprised patients with cerebral malaria, 10, 11 which may have contributed an HbAC effect sufficiently strong to infer protection against severe malaria collectively. The selectivity for cerebral malaria may have been missed because the study groups were too small to allow for appropriate stratifications required to analyze any single one of the largely overlapping disease signs 10, 11 or because no stratifications were made. 9 Cerebral malaria is considered to result from impairments in cerebral perfusion and local alterations of the bloodbrain barrier caused by adherence of parasitized erythrocytes to microvascular endothelial cells, 18, 27 which is mediated by Plasmodium-falciparumerythrocyte-membrane-protein 1 (PfEMP-1) expressed on the surface of parasitized erythrocytes. 28 Recent laboratory studies have shown that HbAC alters the display of PfEMP-1 at the erythrocyte surface, causing an approximately 30% reduction in endothelial adherence. 17 The selectivity of the HbAC effect may indicate a critical role of PfEMP-1 display in the pathogenesis of cerebral malaria. Conversely, it may also indicate that PfEMP-1 display is less critical for other signs of severe malaria.
Whereas HbAC appeared to be selectively associated with cerebral malaria, the negative association of −␣/␣␣ appeared to be limited to severe anemia. This is in agreement with previous findings. A failure of −␣/␣␣ (and −␣/−␣) to protect 56 patients from coma has also been noted by Allen et al 12 in Papua New Guinea but was interpreted as resulting from a poor definition of the cerebral phenotype, which has been found to comprise a variety of etiologies. 29 In our setting, we have also observed heterogeneity in the etiology of syndromes commonly classified as severe malaria. 30 However, the clear negative associations observed with HbS provide strong circumstantial evidence for a predominant role of malaria as the cause of disease in our patient group, given that HbS has never been reported to be associated with protection against diseases other than malaria. 24 More recently, Wambua et al 15 and Pasvol 16 speculated about a possible selectivity of −␣/␣␣ to protect against severe anemia based on an inability to find protection among 19 cases of cerebral malaria.
Our stratifications resulted in the identification of a subgroup of 281 patients with severe anemia without additional signs of disease, who showed no negative association with −␣/␣␣. This finding became apparent on multiple comparisons and therefore was statistically not significant. We believe, however, that it merits some discussion because, with 281 patients, the subgroup was of considerable size and, furthermore, the hypothesis that the association of −␣/␣␣ would be specific for a complicated form of severe anemia may give rise to an interesting idea about the mode of malaria protection conferred by −␣/␣␣.
The pathogenesis of malaria anemia is considered to include intravascular hemolysis, extravascular clearance of parasitized and nonparasitized erythrocytes, and bone-marrow dysfunction, with no understanding yet as to the relative contributions of these factors in mild and severe anemia. 31 Similarly, the mechanism of malaria protection by ␣-thalassemias remains a matter of discussion. Experimental data may support control of parasitemia 32 or selectivity for anemia in general 33 but not selectivity for a complicated form of severe anemia. This, in fact, supports statistical concerns that this part of our −␣/␣␣ findings may be spurious.
On the other hand, 2 lines of evidence may contribute to explain the selectivity of an association of −␣/␣␣ with a complicated form of severe anemia. First, experience with anemia of other etiologies shows that a rapid decrease in hemoglobin concentrations generally causes tissue hypoxia with symptoms resembling those seen as additional complications in complicated forms of severe malaria anemia, whereas very low hemoglobin concentrations may well be tolerated if they develop at a rate sufficiently slow to allow compensatory mechanisms to become effective. 34 Observations of drugresistant malaria suggest that severe malaria anemia without additional complications may develop over a prolonged period. 35, 36 Second, evidence has been presented indicating that −␣/␣␣ may cause an increased erythrocyte turnover. 37 Thus, it may be hypothesized that the 2 forms of severe malaria anemia differ in that they result from a slow and a rapid decrease in hemoglobin concentrations, respectively. The protective effect of −␣/␣␣ might be restricted to the latter because a constitutively accelerated erythrocyte production in −␣/␣␣ may dampen a rapid decrease in hemoglobin concentration, whereas it may have little effect on a slow decrease, which leaves time for maximum stimulation of erythropoiesis irrespective of the constitutive level. Further studies are needed to support these speculations.
The data presented in this study suggest that the specific malaria-protective effects of HbAC and −␣/␣␣ result from interferences of these hemoglobin variants with distinct pathophysiological events. The genetic associations presented provide circumstantial evidence only and do not monitor biological processes directly. They may, however, stimulate attempts to design clinical studies and experimental models to confirm the genetic results at the functional level.
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